A catalyst don’t appear in the overall stoichiometry of the reaction it catalyzes, name: N1,N2-Di-tert-butylethane-1,2-diamine, but it must appear in at least one of the elementary reactions in the mechanism for the catalyzed reaction. 4062-60-6, Name is N1,N2-Di-tert-butylethane-1,2-diamine, molecular formula is C10H24N2. In a Article, authors is Motoshima, Kazunori，once mentioned of 4062-60-6
Liver X receptor (LXR) alpha/beta dual agonists are candidate medicaments for the treatment of metabolic syndrome, because their biological actions include increasing cholesterol efflux mediated by LXRbeta. However, their clinical application is currently limited by their enhancing effect on triglyceride (TG) synthesis mediated by LXRalpha. Combination of an LXRalpha-selective antagonist with an LXRalpha/beta dual agonist may overcome this disadvantage. In the present work, structural development studies of phenethylphenyl phthalimide 9, which possesses LXRalpha/beta dual-antagonistic activity and alpha-glucosidase-inhibitory activity, led to the LXRalpha-selective antagonist 23f. Specific alpha-glucosidase inhibitors were also obtained.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 4062-60-6, help many people in the next few years.name: N1,N2-Di-tert-butylethane-1,2-diamine
Reference：
Metal catalyst and ligand design,
Ligand Template Strategies for Catalyst Encapsulation – NCBI